In Table 1, we can see that HAUS1 expression level in glioma patients has a prognostic value in WHO grade (P ≤ 0.01), IDH mutation status (P ≤ 0.01), and 1p/19q codeletion status (P ≤ 0.01) based on the CGGA and TCGA database. The gene discussed is IDH1; the disease is central nervous system cancer.